海尔生物: 海尔生物关于以集中竞价交易方式回购公司股份的进展公告

Group 1 - The company announced a share repurchase plan with a total expected amount between 100 million and 200 million RMB [1][2] - The repurchase plan was approved on January 13, 2025, and will be implemented within 12 months [1] - The repurchased shares will be used for employee stock ownership plans or equity incentives [1] Group 2 - As of March 31, 2025, the company has repurchased a total of 524,614 shares, accounting for 0.1650% of the total share capital [1] - The total amount spent on repurchased shares is 17,467,616.72 RMB, with an average price range of 31.78 RMB to 34.69 RMB per share [1] - The company will continue to make repurchase decisions based on market conditions and will fulfill information disclosure obligations [2]